Study will allow rapid advancement into participants with chronic HBV infection in Q4 2026 SOUTH SAN FRANCISCO, Calif., Aug. 12, 2026 (GLOBE NEWSWIRE)-- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results